Flex Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Flex Pharma and buy or sell other stocks, ETFs, and their options commission-free!About FLKS
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor.
CEOFrederick E. Pierce, II
CEOFrederick E. Pierce, II
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2014
Founded2014
Employees—
Employees—
FLKS Key Statistics
Market cap3.83M
Market cap3.83M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume403.90K
Average volume403.90K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$108.00
52 Week high$108.00
52 Week low$0.653
52 Week low$0.653
Stock Snapshot
Flex Pharma(FLKS) stock is priced at $6.68, giving the company a market capitalization of 3.83M. It carries a P/E multiple of -0.02.
During the trading day, Flex Pharma(FLKS) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Flex Pharma(FLKS) stock has reached 0, versus its average volume of 403.9K.
The stock's 52-week range extends from a low of $0.65 to a high of $108.00.
The stock's 52-week range extends from a low of $0.65 to a high of $108.00.